Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Price Performance

ATHX opened at $0.00 on Monday. The business’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.02. Athersys has a 1 year low of $0.01 and a 1 year high of $1.99. The firm has a market capitalization of $283,907.40, a PE ratio of 0.00 and a beta of -0.90.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.